5-Hydroxytryptamine (serotonin) subtype 3 antagonists, a major step in prophylaxis and control of cytostatic and radiation-induced emesis.
Bremer
K
K
Augusta-Kranken-Anstalt Bochum, Federal Republic of Germany.
D000932:Antiemetics / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D006801:Humans; D009325:Nausea / Q000188:drug therapy* / Q000517:prevention & control; D011878:Radiotherapy / Q000009:adverse effects*; D012702:Serotonin Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D014839:Vomiting / Q000188:drug therapy* / Q000517:prevention & control
D000932:Antiemetics; D000970:Antineoplastic Agents; D012702:Serotonin Antagonists